A Q&A between Samsung's Young Sohn & Genome Medical's Lisa Alderson

Posted by Genome Medical

 

 

 

Genomics and the Future of Healthcare

A Q&A between Samsung's Young Sohn and Genome Medical's Lisa Alderson

Genomics is transforming healthcare by making it more targeted, personalized and proactive. However, bringing genome-enabled health care to citizens across the U.S. and beyond remains a challenge—mostly due to insurance barriers, a broad lack of clinical understanding, and the sheer volume and complexity of new tests being brought to market.

The Next Wave,” features host Young Sohn, Chairman of the Board, HARMAN and Senior Advisor, Samsung Electronics, talking to our CEO and Co-founder Lisa Alderson about her plans to make genomics more accessible for everyone. They also discuss the ethical questions raised by genomics, as well as the critical role this game-changing technology played in developing Covid vaccines in record time.

 

Topics: Blog, genetic-counseling, genetics-101, genetic-testing, precision-medicine, cancer-genetics, dna, cardio-genetics, pediatric-genetics, proactive-genetics, reproductive-genetics

Latest Posts

Partner Support

Provide standard-of-care genetics to more patients through virtual, on-demand specialty care.

LEARN MORE

Individual Service

Interested in exploring your DNA? Our genetic experts can help you make the right decisions.

START NOW